RxDoctor Payments Data

Zsolt Garami, MD

General Practice · Houston, TXNPI 1023387339

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Longeviti Neuro Solutions Inc at 41.6% of the total. Among general practice clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$110,549in general payments, 2019–2025

Across 218 payments — averaging $507.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Longeviti Neuro Solutions Inc$46K
  • Silk Road Medical, Inc.$24K
  • W. L. Gore & Associates, Inc.$20K
  • Neural Analytics, Inc.$10K
  • Siemens Medical Solutions USA, Inc.$6K
  • Boston Scientific$702
  • plus $4K from 26 others

What the payments were for

  • Consulting fees$52,82048%
  • Speaking & faculty fees$34,05631%
  • Travel & lodging$11,82311%
  • Food & beverage$11,85011%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$110,549 in reported general payments places this provider in the 95th percentile of 8,074 general practice providers in Texas.

See all general practice providers in Texas

Medicare billing

Part B allowed, 2024
$133,102
Medicare patients
2,780
Services billed
4,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other general practice in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →